CLINICAL_TRIALS
trial_result
· 2021-05-17
Clinical Trial Update: Riociguat in Children With Pulmonary Arterial Hypertension (PAH) [Phase 3]
Summary
Phase 3 trial update for riociguat in children with pulmonary arterial hypertension, with results posted in May 2021 and the study currently not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Hypertension, Pulmonary | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-05-17